Antiprotozoal Activity of Essential Oils by Lianet Monzote et al.
167
Agriculturae Conspectus Scientifi cus . Vol. 77 (2012) No. 4 (167-175)
REVIEW ARTICLE
Summary
In the present scenario of protozoal infections, new drugs are urgently needed to treat 
and control infections such as malaria, sleeping sickness, Chagas disease, leishmania-
sis and intestinal infections, which aff ect millions of people each year. In this review, 
we are focusing on articles related to antiprotozoal essential oils extracted from plants 
that have been published during the last 20 years. Th e data analyzed indicate that es-
sential oils could be promising antiprotozoal agents, opening perspectives to the dis-
covery of more eff ective drugs of vegetal origin for the treatment of diseases caused by 
protozoa.
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Introduction
Essential oils (EOs) are volatile extracts obtained through 
steam distillation of aromatic plants (Post-White and Nicholson, 
2007). Th e aromatic oily liquids can be obtained from fl owers, 
buds, seeds, leaves, twigs, bark, herbs, wood, fruits and roots, 
commonly extracted by distillation using a Clevenger’s appara-
tus (Burt, 2004). Th ere are an estimated 3000 known EOs about 
300 of which are commercially important destined chiefl y for the 
fl avour and fragrances market (Van de Braak and Leijten, 1999).
Th e medicinal values of EOs have been utilized in various 
forms. Th e antimicrobial actions of EOs are one of the most ex-
tensively studied aspects of botanical medicine. EOs has been 
shown to exhibit antibacterial (Burt, 2004), antiviral (Edris, 
2007), antimycotic (Pisseri et al., 2008) and antiparasitic activity 
(Antony et al., 2005). Th ese characteristics are possibly related 
to the presence of diverse compounds in the EOs (Mahmoud 
and Croteau, 2002). Th e purpose of this paper is to provide an 
overview of the published data about antiparasitic activity of 
EOs and their components, with special reference to parasitic 
infections in humans.
With the objective to obtain the reports about antiparasitic 
potentialities of EOs, an electronic search was performed from 
1988 to the present. We have consulted “Pubmed” database, 
which is one of the most used by academics, medical students and 
primary care practitioners according to several surveys (Cullen, 
2002; DeGroote and Dorsch, 2003; Tannery et al., 2002). In par-
allel, journals specifi cally dedicated to EO research were also re-
viewed (Journal of Essential Oil Research, Flavour and Fragrance 
Journal, International Journal of Essential Oil Th erapeutics, and Journal 
of Essential Oil-Bearing Plants). Th e search was performed using 
the keyword essential oil combined with: parasite, Plasmodium, 
Trypanosoma, Leishmania, Toxoplasma and Trichomonas, re-
spectively. Th e reports related to antiprotozoal activity of EOs 
were analyzed. Th ose reports concerning animal parasites and 
plants/agriculture parasites were excluded.
Properties and Components of Antiprotozoal 
Essential Oils 
Figure 1 shows an increase in publications related to anti 
parasitic protozoal essential oils, indicating a steady increase 
in scientifi c research and interest during the last few years. A 
compilation of antiparasitic essential oils is presented in Table 
1. Cymbopogon citratus and Ocimum gratissimum were the 
plants most investigated against Plasmodium, Trypanosoma 
and Leishmania parasites. Th e second most cited plants were 
Ocimum basilicum, Origanum vulgare and Th ymus vulgaris stud-
ied against Trypanosoma cruzi and intestinal parasites. A corre-
lation between the number of reports and the diseases that cause 
higher morbidity and mortality can be observed: 22 reports about 
Plasmodium, 14 against Trypanosoma, 26 against Leishmania, 
three against Trichomonas, and four intestinal protozoa.
Th e active components of EOs can be isolated by HPLC and 
gas liquid chromatography and characterized by diff erent de-
tectors (mainly mass spectrometry). Major components can 
constitute up to 85% of the EO, whereas other components are 
present only in trace amounts (Bauer et al., 1985). Th e composi-
tion of EOs from a particular species of plant can diff er between 
harvesting seasons, geographical sources and parts of the same 
plant. Nevertheless, EOs produced from herbs harvested during 
or immediately aft er fl owering generally possesses the strong-
est activity (Burt, 2004). Th e main constituents of the EOs with 
antiprotozoal activity are monoterpenoids (linalool, terpinen-
4-ol, thymol, carvacrol, citral, limonene, α-pinene, γ-terpinene, 
α-phellandrene, and p-cymene), sesquiterpenes (β-caryophyllene, 
nerolidol, α-copaene, cyperene, and germacrene D) and phenyl-
propanoids (eugenol, methyl chavicol, and cinnamaldehyde), 
which are responsible of their biological eff ects. A list of antipar-
asitic essential oil components is presented in Table 2.
Antiparasitic Eff ects of Plant-Derived EOs
Antiplasmodial Activity. Th e Amazonian Indians from 
Brazil treat malaria with an inhalation of vapor obtained from 
leaves of Virola surinamensis. Th e EOs obtained from adult and 
plantlet leaves (rich in α-pinene, p-cymene, and (E)-nerolidol) 
had caused 100% of growth inhibition aft er 48 h in the develop-
ment of the young trophozoite to schizont stage of Plasmodium 
falciparum (Lopes et al., 1999). Nerolidol was identifi ed in this 
work as one of the active constituents, which was later recon-
fi rmed by Rodrigues Goulart and co-workers, demonstrating a 
median inhibitory concentration (IC50) of 760 nM (Rodrigues 
et al., 2004). Farnesol was also identifi ed as an antiplasmodial 
sesquiterpene alcohol (Lopes et al., 1999). 
Th e EO of Lippia multifl ora is another nerolidol-rich anti-
plasmodial EO. It was tested on in vitro cultures of P. falciparum 
(chloroquine-sensitive and resistant strains). Th e EO inhibited 
the growth of parasites and when tested on a highly synchronized 
culture, the oil inhibited growth mostly at the trophozoite-schi-
zont step, indicating their potential eff ect (Valentin et al., 1995).
Five EOs extracted from the Cameroonian plants (Antidesma 
laciniatum, Hexalobus crispifl orus, Pachypodanthium confi ne, 
Xylopia aethiopica and Xylopia phloiodora) were evaluated in 
regard to their anti-plasmodial eff ect. Th e oils were active against 









































































Figure 1. Number of articles found in MEDLINE about 
human antiparasitic EO from plants by year
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Plant Essential Oil Family Parasitic organism Reference 
Achillea millefolium L. Asteraceae Leishmania amazonensis
Trypanosoma cruzi
Santos et al., 2010 
Santoro et al., 2007a
Aframomum sceptrum (Oliv. & T. Hanb.) K. 
Schum. 
Zingiberaceae Trypanosoma brucei 
Trichomonas vaginalis
Cheikh-Ali et al., 2011
Ambrosia scabra Hook. & Arn. Asteraceae Plasmodium falciparum Sülsen et al., 2008 
Ambrosia tenuifolia Spreng. Asteraceae Plasmodium falciparum
Trypanosoma cruzi
Sülsen et al., 2008 
Annona foetida Mart. Annonaceae Leishmania guyanensis Costa et al., 2009 
Antidesma laciniatum Müll. Arg. Phyllanthaceae Plasmodium falciparum Boyom et al., 2003 
Artemisia abyssinica Sch. Bip. Asteraceae Leishmania donovani
Leishmania aethiopica
Tariku et al., 2010 
Artemisia gorgonum Webb Asteraceae Plasmodium falciparum Ortet et al., 2010 
Artemisia herba-alba Asso. Asteraceae Leishmania major
Leishmania tropica
Hatimi et al., 2001 
Baccharis dracunculifolia DC. Asteraceae Leishmania donovani Parreira et al., 2010
Chenopodium ambrosioides L. Chenopodiaceae Leishmania amazonensis
Leishmania donovani
Monzote et al., 2006
Monzote et al., 2007a
Cochlospermum planchonii Hook. f. ex Planch. Cochlospermaceae Plasmodium falciparum Benoit-Vical et al., 1999
Cochlospermum tinctorium A. Rich. Cochlospermaceae Plasmodium falciparum Benoit-Vical et al., 1999
Copaifera cearensis Huber ex Ducke Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera langsdorfii Desf. Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera lucens Dwyer Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera martii Hayne Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera multijuga Hayne Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera officinalis (Jacq.) L. Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera paupera (Herzog) Dwyer Fabaceae Leishmania amazonensis Santos et al., 2008 
Copaifera reticulata Ducke Fabaceae Leishmania amazonensis Santos et al., 2008 
Croton cajucara Benth. Euphorbiaceae Leishmania amazonensis Rosa et al., 2003 




Plasmodium bergheia  
Trypanosoma cruzi
Pedroso et al., 2006
Santin, et al., 2009 
Oliveira et al., 2009 
Machado et al., 2010b 
Tchoumbougnang et al., 2005 
Santoro et al., 2007a
Daucus crinitus Desf. Apiaceae Plasmodium falciparum Lanfranchi et al., 2010
Hagenia abyssinica J.F. Gmel. Rosaceae Trypanosoma bruceia Nibret and Wink, 2010
Helichrysum cymosum (L.) Less. Asteraceae Plasmodium falciparum van Vuuren et al., 2006
Hexalobus crispiflorus A. Rich. Annonaceae Plasmodium falciparum Boyom et al., 2003 
Juniperus oxycedrus L. Cupressaceae Leishmania infantum Machado et al., 2010b
Lavandula angustifolia Mill. Lamiaceae Giardia duodenalis 
Trichomonas vaginalis
Moon et al., 2006 
Lavandula × intermedia Emeric ex Loisel. Lamiaceae Giardia duodenalis 
Trichomonas vaginalis
Moon et al., 2006 
Leonotis ocymifolia (Burm. f.) Iwarsson Lamiaceae Trypanosoma bruceia Nibret and Wink, 2010
Licaria cannella (Meisn.) Kosterm. Lauraceae Leishmania amazonensis Silva et al., 2009 
Lippia alba (Mill.) N.E. Br. ex Britton & P. Wilson Verbenaceae Leishmania chagasi
Trypanosoma cruzi
Escobar et al., 2010
Lippia citrodora Kunth Verbenaceae Leishmania chagasi
Trypanosoma cruzi
Escobar et al., 2010
Lippia dulcis Trevir. Verbenaceae Leishmania chagasi
Trypanosoma cruzi
Escobar et al., 2010
Lippia graveolens Kunth Verbenaceae Giardia lamblia Machado et al., 2010a
Lippia javanica (Burm f.) Spreng. Verbenaceae Plasmodium falciparum Manenzhe et al., 2004
Lippia micromera Schauer Verbenaceae Leishmania chagasi
Trypanosoma cruzi
Escobar et al., 2010
Lippia multiflora Moldenke Verbenaceae Plasmodium falciparum Boyom et al., 2003 
Lippia origanoides Kunth Verbenaceae Leishmania chagasi
Trypanosoma cruzi
Escobar et al., 2010
Lippia sidoides Cham.  Verbenaceae Leishmania chagasi Oliveira et al., 2009
Melaleuca alternifolia Cheel Myrtaceae Leishmania major
Trypanosoma bruceia
Mikus et al., 2000 
Melissa officinalis L. Lamiaceae Leishmania major
Trypanosoma bruceia
Mikus et al., 2000 
Moringa stenopetala (Baker f.) Cufod. Moringaceae Trypanosoma bruceia Nibret and Wink, 2010
Myoporum crassifolium Forster & G. Forster Myoporaceae Leishmania amazonensis Billo et al., 2005 
Myrtus communis L. Myrtaceae Plasmodium falciparum Milhau et al., 1997 
Ocimum basilicum L. Lamiaceae Giardia lamblia 
Leishmania donovani 
Trypanosoma cruzi
de Almeida et al., 2007
Zheljazkov et al., 2008 
Hoet et al., 2006 
Table 1. Plant-derived essential oils that showed antiparasitic activity (1988-present)
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extracted from H. crispifl orus (dominated by the sesquiterpe-
nes α-copaene, cyperene, alloaromadendrene, δ-cadinene, cala-
corene, and τ-cadinol), at a IC50 of 2 g/mL (Boyom et al., 2003).
The antimalaria l and toxicological properties of 
Cochlospermum tinctorium and C. planchonii EOs prepared 
from their leaves were studied. Aft er 24 and 72 h contact be-
tween the oils and the parasite culture, C. planchonii EO (rich 
in sesquiterpene hydrocarbons β-caryophyllene and (E,E)-α-
farnesene) showed an IC50 of 22-35 g/mL against P. falcipa-
rum. Th e cytotoxicity of oils was assessed on the K562 cell line 
and showed IC50 values ranging between 33 and 2000  g/mL 
(Benoit-Vical et al., 1999).
Antitrypanosomal Activity. Th e anti-proliferative eff ect of 
Cymbopogon citratus (lemongrass) oil was demonstrated against 
Trypanosoma cruzi. Th e IC50 of the oil against free cells of the 
epimastigote and trypomastigote forms was 126.5 and 15.5 g/
mL, respectively, aft er 24 h of treatment. An IC50 of 5.1 g/mL 
aft er 48 h of treatment of intracellular amastigote in mouse 
peritoneal macrophage was determined. C. citratus oil is rich in 
citral (a mixture of geranial and neral) and this was shown to be 
responsible for the trypanocidal activity (Santoro et al., 2007a).
Th e trypanocidal activities of clove (Syzigium aromaticum), 
basil (Ocimum basilicum) and yarrow (Achillea millefolium) 
essential oils were determined on T. cruzi epimastigote and 
bloodstream trypomastigote forms. Th e clove oil (dominated by 
eugenol) was found to be the most eff ective, with an IC50 value 
of 99.5 g/mL for epimastigotes and 57.5 g/mL for trypomas-
tigotes (Santoro et al., 2007b). 
Strychnos spinosa is used in African traditional medicine to 
treat African trypanosomiasis. Th e EO obtained from the leaves 
was evaluated against Trypanosoma brucei brucei bloodstream 
forms, as a model to predict antitrypanosomal activity, and on 
mammalian cells (J774 murine macrophages) to evaluate the se-
lectivity of the antitrypanosomal eff ect. Th e EO was active on 
the parasites; showing an IC50 of 13.5 g/mL with a selectivity 
index of 4.4. Th e bioactive agents were determined to be linal-
ool (IC50 = 2.5 μg/mL) and nerolidol (IC50 = 1.7 μg/mL), with a 
selectivity index higher than 30 (Hoet et al., 2006). Th e activi-
ties of these components on T. brucei brucei have very recently 
been confi rmed (Nibret and Wink, 2010).
Aframomum sceptrum is found in humid forest regions of 
tropical Central Africa and has been used in traditional medi-
cine as an antiparasitic in Ivory Coast (Okpekon et al., 2004) 
and Nigeria (Idu and Osemwegie, 2007). Th e EO from the rhi-
zome of A. sceptrum has shown notable in-vitro antiparasitic 
activity on T. brucei brucei with a minimum lethal concentra-
tion (MLC) of 1.51 μL/mL, which may be attributable to a high 
concentration of caryophyllene oxide (10%); the MLC of caryo-
phyllene oxide on T. brucei brucei was determined to be 0.1 mg/
mL (Cheikh-Ali et al., 2011). 
 




Holetz et al., 2003 
Ueda-Nakamura et al., 2006 
Oliveira et al., 2009 
Tchoumbougnang et al., 2005
Ocimum sanctum L. Lamiaceae Leishmania donovani Zheljazkov et al., 2008
Origanum virens L. Lamiaceae Giardia lamblia Machado et al., 2010a




Force et al., 2000 
Force et al., 2000 
Force et al., 2000 
Santoro et al., 2007c
Pachypodanthium confine Engl. & Diels Annonaceae Plasmodium falciparum Boyom et al., 2003 




Monzote et al., 2010
Piper claussenianum (Miq.) C. DC. Piperaceae Leishmania amazonensis Marques et al., 2010
Rosmarinus officinalis L. Lamiaceae Plasmodium falciparum Milhau et al., 1997 
Salvia albicaulis Benth. Lamiaceae Plasmodium falciparum Kamatou et al., 2007
Salvia dolomitica Codd Lamiaceae Plasmodium falciparum Kamatou et al., 2007
Satureja punctata (Benth.) Briq. Lamiaceae Leishmania donovani
Leishmania aethiopica
Tariku et al., 2010 
Strychnos spinosa Lam. Loganiaceae Trypanosoma bruceia Hoet et al., 2006 
Syzigium aromaticum L. Myrtaceae Trypanosoma cruzi
Giardia lamblia
Santoro et al., 2007b
Machado et al., 2011
Tetradenia riparia (Hochst.) Codd Lamiaceae Plasmodium falciparum Campbell et al., 1997
Thymbra capitata Cav. Lamiaceae Giardia lamblia Machado et al., 2010a
Thymus capitellatus Hoffmanns. & Link Lamiaceae Leishmania infantum Machado et al., 2010b




Behnia et al., 2008 
Mikus et al., 2000 
Mikus et al., 2000 
Santoro et al., 2007c
Thymus zygis L. Lamiaceae Giardia lamblia Machado et al., 2010a
Virola surinamensis (Rol. ex Rottb.) Warb. Myristicaceae Plasmodium falciparum Lopes et al., 1999 
Xylopia aethiopica (Dunal) A. Rich. Annonaceae Plasmodium falciparum Boyom et al., 2003 
Xylopia phloiodora Mildbr. Annonaceae Plasmodium falciparum Boyom et al., 2003 
a As an experimental model organism. 
Table 1 - continued
Agric. conspec. sci. Vol. 77 (2012) No. 4
171Antiprotozoal Activity of Essential Oils
A number of Lippia spp. (Verbenaceae) from Colombia were 
screened for antitrypanosomal activity against T. cruzi, and 
those samples that were rich in either neral, geranial, geraniol, 
thymol, or carvacrol were particularly active (Escobar et al., 
2010). Th ese workers also showed that geranial, carvacrol, and 
thymol exhibited antitrypanosomal activity.
Antileishmanial Activity. A linalool-rich EO from leaves of 
Croton cujacara has been used successfully against Leishmania 
parasite. Th e oil showed an IC50 of 8.3 ng/mL and 22 ng/mL 
against promastigotes and amastigotes of Leishmania amazon-
ensis and no toxic eff ects on mammalian cells were observed 
(Rosa et al., 2003). 
Th e eugenol-rich essential oil of Ocimum gratissimum progres-
sively inhibited L. amazonensis growth at concentrations ranging 
from 100 to 1000 μg/mL. Th e IC50 of this oil against promastig-
otes and amastigotes was 135 and 100 μg/mL, respectively. Th e 
product showed no cytototoxic eff ects against mammalian cells 
(Ueda-Nakamura et al., 2006). Both Ocimum basilicum and O. 
sanctum (both also rich in eugenol) showed antileishmanial ac-
tivity on L. donovani promastigotes, but were devoid of cytotox-
icity on kidney fi broblast or kidney epithelial cells (Zheljazkov et 
al., 2008). Eugenol, a phenylpropanoid extracted from O. gratis-
simum, showed an IC50 of 80 μg/mL against promastigote forms 
of L. amazonensis (Ueda-Nakamura et al., 2006). 
 
Compound Chemical class Parasitic organism Reference 
Alloaromadendrene Sesquiterpene hydrocarbon Trypanosoma brucei Mikus et al., 2000 
Aromadendrene Sesquiterpene hydrocarbon Leishmania major Mikus et al., 2000 
Asarone Phenylpropanoid Trypanosoma brucei Nibret and Wink, 2010 
Benzyl isothiocyanate Isothiocyanate Trypanosoma brucei Nibret and Wink, 2010 
α-Bisabolol Sesquiterpenoid Leishmania infantum Morales-Yuste et al., 2010
δ-Cadinene Sesquiterpene hydrocarbon Leishmania donovani Santos et al., 2008 
Camphor Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
δ-3-Carene Monoterpene hydrocarbon Leishmania donovani Santos et al., 2008 
Carvacrol Aromatic monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Carvone Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
β-Caryophyllene Sesquiterpene hydrocarbon Leishmania donovani
Trypanosoma brucei 
Santos et al., 2008 
Nibret and Wink, 2010 
Caryophyllene oxide Sesquiterpenoid Trypanosoma brucei Nibret and Wink, 2010 
α-Cedrene Sesquiterpene hydrocarbon Trypanosoma brucei Nibret and Wink, 2010 
Cinnamaldehyde Phenylpropanoid Trypanosoma brucei Nibret and Wink, 2010 
Citral (mixture of geranial and neral) Monoterpenoid Leishmania amazonensis
Leishmania donovani 
Trypanosoma cruzi
Santin et al., 2009 
Santos et al., 2008 
Santoro et al., 2007a 
Citronellal Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Estragole Phenylpropanoid Trypanosoma brucei brucei Nibret and Wink, 2010 
Eugenol Phenylpropanoid Giardia lamblia
Leishmania amazonensis 
Trypanosoma brucei 
de Almeida et al., 2007 
Ueda-Nakamura et al., 2006 
Nibret and Wink, 2010 
Farnesol Sesquiterpenoid Plasmodium falciparum Rodrigues et al., 2004 
Germacrene D Sesquiterpene hydrocarbon Trypanosoma cruzi Arruda et al., 2005 
α-Humulene Sesquiterpene hydrocarbon Leishmania donovani Santos et al., 2008 
Limonene oxide Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Linalool Monoterpenoid Giardia lamblia
Plasmodium falciparum 
Trypanosoma brucei 
de Almeida et al., 2007 
Rodrigues et al., 2004 
Hoet et al., 2006; Nibret and Wink, 2010
Myrtenal Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
(E/Z)-Nerolidol Sesquiterpenoid Leishmania amazonensis
Plasmodium falciparum 
Trypanosoma brucei
Arruda et al., 2005 
Lopes et al., 1999: Rodrigues et al., 2004 
Hoet et al., 2006 
(Z)-Nerolidol Sesquiterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Oplopanone Sesquiterpenoid Trypanosoma cruzi Biavatti et al., 2001 
α-Phellandrene Sesquiterpene hydrocarbon Leishmania major
Trypanosoma brucei
Mikus et al., 2000 
α-Pinene Monoterpene hydrocarbon Leishmania major
Trypanosoma brucei
Mikus et al., 2000 
Piperitone Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Sabinene Monoterpene hydrocarbon Trypanosoma brucei Mikus et al., 2000 
Safrole Phenylpropanoid Trypanosoma brucei Nibret and Wink, 2010 
Terpinen-4-ol Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Mikus et al., 2000 
Thujone Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Thymol Aromatic monoterpenoid Trypanosoma brucei
Trypanosoma cruzi
Nibret and Wink, 2010 
Santoro et al., 2007c 
Verbenone Monoterpenoid Trypanosoma brucei Nibret and Wink, 2010 
Table 2. Essential oil components known to exhibit antiparasitic activity
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Th e use of copaiba oils to treat leishmaniasis is cited in 
several ethnopharmacological studies. Eight diff erent kinds 
of Brazilian copaiba oils (Copaifera cearensis, C. langsdor, C. 
lucens, C. martii, C. multijuga, C. offi  cinalis, C. paupera and C. 
reticulata) were screened for antileishmanial activity (Santos et 
al., 2008). Copaiba oils showed variable levels of activity against 
promastigote forms with IC50 values in the range between 5 and 
22 g/mL. Th e most active EOs were from C. reticulata and C. 
multijuga (both rich in β-caryophyllene). Th e cytotoxicity of C. 
reticulata EO was low against J774G8 macrophages.
Chenopodium oil showed an IC50 against promastigotes and 
amastigotes of L. amazonensis of 3.7 and 4.6 μg/mL, respective-
ly (Monzote et al., 2006); while against L. donovani was of 4.5 
and 5.1 μg/mL (Monzote et al., 2007a). Th e EO was eff ective by 
intraperitoneal and oral routes when BALB/c mice experimen-
tally infected with L. amazonensis were treated (Monzote et al., 
2007b). A synergic action has been observed in conjunction with 
the pentamidine, drug clinically used, in promastigotes growing 
freely in Schneider’s medium (Monzote et al., 2007c).
Th e EO from Artemisia herba-alba was tested for antileish-
manial activity against L. tropica and L. major, and showed leish-
manicidal activity of 2 μg/mL against the two organisms (Hatimi 
et al., 2001). Similarly, A. abyssinica EO was active against L. 
donovani and L. aethiopica (Tariku et al., 2010).
Activity against Intestinal Protozoa. Th e eff ect of Ocimum ba-
silicum EO on Giardia lamblia was studied in vitro. Pretreatment 
of peritoneal mouse macrophages with 2 mg/mL EOs dilution 
reduced in 79% the association index between these macrophages 
and G. lamblia, with a concomitant increase by 153% on nitric 
oxide production by the G. lamblia-ingested macrophages. One 
of the major components of O. basilicum EO was linalool, which 
was able to kill 100% of G. lamblia parasites aft er 1 h of incuba-
tion at 300 g/mL (de Almeida et al., 2007). 
Two EOs derived from Lavandula angustifolia and L.  in-
termedia were investigated for antiparasitic activity against the 
human protozoal pathogens Giardia lamblia, Trichomonas vagi-
nalis, and Hexamita infl ata. Th is study has demonstrated that 
low (≤1%) concentrations of L. angustifolia and L.  interme-
dia oil can completely eliminate G. lamblia in culture. At 0.1% 
concentration, L. angustifolia oil was found to be slightly more 
eff ective than L.  intermedia oil against G. lamblia (Moon et 
al., 2006). Th ese Lavandula EOs are both dominated by linalool 
(Lane and Mahmoud, 2008), which may be responsible for the 
observed activity.
Th e EO isolated from Th ymus vulgaris of Iranian origin was 
active against the trophozoites of E. histolytica, which was more 
eff ective than hydroalcoholic and hexane extracts (Behnia et al., 
2008). T. vulgaris oil is dominated by thymol (Stoilova et al., 2008) 
and this phenolic component is likely responsible for the activity. 
A recent report by Machado et al. (2010a) has shown essential 
oils rich in phenolic compounds to exhibit antigiardial activity.
Oil of Mediterranean oregano, Origanum vulgare, was orally 
administered to 14 adult patients whose stools tested positive for 
enteric protozoa: Blastocystis hominis, Entamoeba hartmanni 
and Endolimax nana. Aft er six weeks of supplementation with 
600 mg emulsifi ed oil of oregano daily, there was complete dis-
appearance of E. hartmanni (four cases), E. nana (one case), and 
B. hominis (eight cases). In addition, Blastocystis hominis scores 
declined in three additional cases. Gastrointestinal symptoms 
improved in seven of the 11 patients who had tested positive for 
Blastocystis hominis (Force et al., 2000). Note that O. vulgare 
oil, like T. vulgaris oil, is rich in thymol as well as carvacrol 
(D’Antuono et al., 2000).
Mechanism of Antiparasitic Activity of EOs 
An important feature of the EOs and their components is 
their hydrophobicity and low density that can enhance the tar-
geting of active components within the oil to intracellular para-
sites (Boyom et al., 2003). It might also off er alternative delivery 
routes, including transcutaneous delivery following scarifi cation 
or patch application (Antony et al., 2005).
Two mechanisms of action can be attributed to the effi  cacy 
of plant EOs: their direct antiparasitic action and their immu-
nomodulatory properties (Antony et al., 2005). Th e mechanism 
of action of the EOs has not been studied in great detail and there 
are large numbers of chemical compounds present in the oils. 
It is likely that the pharmacologic action would not be attribut-
able to one specifi c mechanism but to several targets in the cell 
(Valentin et al., 1995). In addition, the inherent activity of the 
oil can be expected to relate their chemical compositions. Th at 
is, the proportions in which they are present and the interactions 
between them are responsible for their pharmacological activity. 
Direct Antiparasitic Activity. In most of the scientifi c arti-
cles only ultrastructural studies have been reported [see (Santoro 
et al., 2007c; Oliveira et al., 2009; Santin et al., 2009; Adade and 
Souto-Padrón, 2010), for example]. Th ese studies are important 
in compounds without previous knowledge about their mech-
anism of action, in determining their targets in the parasites. 
Considerable mitochondrial swelling was observed in EOs from 
O. gratissimum-treated L. amazonensis promastigotes and amas-
tigotes, which had the inner mitochondrial membrane altered, 
with a signifi cant increase in the number of cristae; in some 
amastigotes the mitochondrial matrix became less electron-
dense (Ueda-Nakamura et al., 2006). 
Other mechanisms of action have been suggested. Th e EO 
from O. basilicum (2 mg/mL) as well as purifi ed linalool (300 
μg/mL) showed protease inhibitory activity, mainly of cyste-
ine proteases (de Almeida et al., 2007). A number of essential 
oils (Setzer et al., 2007a; Setzer et al., 2007b; Stokes et al., 2007) 
and essential oil components (Setzer et al., 2007b) have shown 
inhibitory activity against the cysteine protease cruzain, pre-
sumably due to binding of these hydrophobic agents to the hy-
drophobic recognition site of the enzyme (Ogungbe and Setzer, 
2008). Th e EOs from V. surinamensis and nerolidol have been 
shown to inhibit glycoprotein biosynthesis by competing with 
the biosynthesis of isoprenoid derivatives (Lopes et al., 1999; 
Rodrigues et al., 2004).
Immunostimulatory Activity of EOs. Th e diverse structur-
al and biochemical properties, their life cycles, and pathogenic 
mechanisms of protozoal parasites has led to the diff erent and 
complex immune responses by vertebrate hosts, including humans 
and animals. Most protozoal infections are chronic because of 
weak innate immunity and ability of parasite to evade or resist 
elimination by an adaptive immune response. Furthermore, 
many antiparasitic drugs are not eff ective at killing the organ-
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ism. Individuals living in endemic areas require repeated chem-
otherapy because of continued exposure, and such treatment is 
oft en not possible due to cost and logistical problems. Th e de-
velopment of prophylactic vaccines for parasites has long been 
considered and important goal for developing countries (Costa 
et al., 2009). However, the progress in the development of vac-
cines against protozoal infections tends to be slow and arduous 
(Parreira et al., 2010). In this scenario, immunotherapy has been 
adopted as a new situation together with antiprotozoal agents. 
Th e immunomodulatory eff ects of some EOs have demon-
strated their usefulness for treating infectious diseases (Antony 
et al., 2005). Th e EO from C. cajucara and C. ambrosioides en-
hanced macrophage nitric oxide production, which is a potent 
intracellular parasite-killing mechanism in macrophages (Rosa 
et al., 2003; Pedroso et al., 2006). Th e anti-infl ammatory activity 
of EOs has been also reported, which contribute to protecting 
the host from the damaging eff ects of the infl ammatory compo-
nents of the immune response as they control the parasitic in-
fections (Antony et al., 2005). Melaleuca alternifolia EO caused 
the stimulation of lymphocytes and increased the secretion of 
the anti-infl ammatory cytokines (Machado et al., 2010a), while 
O. sanctum oil demonstrated anti-infl ammatory activity due to 
dual inhibition of arachidonate metabolism (Tchoumbougnang 
et al., 2005).
Nigella sativa seed oil has been found to reduce parasitemia 
and to extend the life span of T. brucei infected rats (Ekanem et 
al., 2008). N. sativa seed oil treatment resulted in increased he-
moglobin concentration, increased red blood cell, white blood 
cell, and platelet counts, suggesting that the oil has trypanocidal 
properties as well as host immune stimulant activity.
Conclusion
In this review, we presented an overview of the diff erent uses 
of EOs against parasitic protozoa. One of the most interesting 
areas of application for EOs is the inhibition of growth and re-
duction of parasite burden. Th e data collected indicate that EOs 
can serve as promising antiprotozoal agents, opening perspectives 
to the discovery of new alternatives drugs of vegetal origin for 
treatment of protozoal diseases. Nevertheless, the main results 
about potentialities of EOs have been demonstrated in in-vitro 
studies. Pharmacological tests in in-vivo models are needed to 
confi rm the therapeutic potential of essential oils against par-
asites. Additional toxicity evaluations must be performed, to-
gether with the elucidation of these mechanisms would provide 
insights that may prove useful for technological applications. Th e 
international standardisation of EOs can help to advances these 
natural products as commercially available and effi  cacious new 
drugs to combat protozoal diseases. We hope that this paper 
stimulates interest for researches of the potentialities of EOs as 
antiprotozoal drugs. 
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